A detailed history of Lazard Asset Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 444,146 shares of GILD stock, worth $41 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
444,146
Previous 960,982 53.78%
Holding current value
$41 Million
Previous $65.9 Million 43.54%
% of portfolio
0.05%
Previous 0.09%

Shares

42 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$66.59 - $83.99 $34.4 Million - $43.4 Million
-516,836 Reduced 53.78%
444,146 $37.2 Million
Q2 2024

Aug 14, 2024

SELL
$63.15 - $72.88 $552,625 - $637,772
-8,751 Reduced 0.9%
960,982 $65.9 Million
Q1 2024

May 14, 2024

BUY
$71.58 - $87.29 $1.77 Million - $2.15 Million
24,683 Added 2.61%
969,733 $71 Million
Q4 2023

Feb 14, 2024

BUY
$73.27 - $83.09 $18.1 Million - $20.5 Million
246,614 Added 35.31%
945,050 $76.6 Million
Q3 2023

Nov 14, 2023

SELL
$73.94 - $80.67 $18.4 Million - $20.1 Million
-248,784 Reduced 26.26%
698,436 $52.3 Million
Q2 2023

Aug 14, 2023

SELL
$76.01 - $86.7 $19.2 Million - $21.8 Million
-251,974 Reduced 21.01%
947,220 $73 Million
Q1 2023

May 15, 2023

BUY
$77.31 - $88.08 $27.4 Million - $31.3 Million
354,971 Added 42.05%
1,199,194 $99.5 Million
Q4 2022

Feb 14, 2023

BUY
$62.32 - $89.47 $20.2 Million - $29.1 Million
324,758 Added 62.52%
844,223 $72.5 Million
Q3 2022

Nov 14, 2022

BUY
$59.54 - $68.01 $7.21 Million - $8.24 Million
121,154 Added 30.42%
519,465 $32 Million
Q2 2022

Aug 09, 2022

BUY
$57.72 - $65.01 $11 Million - $12.4 Million
190,766 Added 91.92%
398,311 $24.6 Million
Q1 2022

May 13, 2022

BUY
$57.92 - $72.58 $1.4 Million - $1.76 Million
24,215 Added 13.21%
207,545 $12.3 Million
Q4 2021

Feb 09, 2022

BUY
$64.88 - $73.64 $11.1 Million - $12.7 Million
171,828 Added 1493.9%
183,330 $13.3 Million
Q3 2021

Nov 15, 2021

BUY
$67.69 - $73.03 $470,851 - $507,996
6,956 Added 153.01%
11,502 $803,000
Q2 2021

Aug 12, 2021

SELL
$63.47 - $69.35 $7.19 Million - $7.86 Million
-113,359 Reduced 96.14%
4,546 $312,000
Q1 2021

May 14, 2021

SELL
$60.0 - $68.46 $3.67 Million - $4.19 Million
-61,190 Reduced 34.17%
117,905 $7.62 Million
Q4 2020

Feb 11, 2021

SELL
$56.65 - $64.55 $6.3 Million - $7.18 Million
-111,173 Reduced 38.3%
179,095 $10.4 Million
Q3 2020

Nov 13, 2020

SELL
$62.1 - $78.08 $8.66 Million - $10.9 Million
-139,430 Reduced 32.45%
290,268 $18.3 Million
Q2 2020

Aug 13, 2020

BUY
$72.34 - $84.0 $24.1 Million - $28 Million
333,717 Added 347.69%
429,698 $33.1 Million
Q1 2020

May 14, 2020

SELL
$62.63 - $80.22 $16.3 Million - $20.8 Million
-259,807 Reduced 73.02%
95,981 $7.18 Million
Q4 2019

Feb 13, 2020

BUY
$61.62 - $67.78 $478,356 - $526,176
7,763 Added 2.23%
355,788 $23.1 Million
Q3 2019

Nov 14, 2019

BUY
$62.51 - $69.0 $4.25 Million - $4.69 Million
67,995 Added 24.28%
348,025 $22.1 Million
Q2 2019

Aug 14, 2019

BUY
$61.87 - $69.38 $4.12 Million - $4.62 Million
66,542 Added 31.17%
280,030 $18.9 Million
Q1 2019

May 13, 2019

BUY
$62.53 - $70.05 $2.81 Million - $3.14 Million
44,885 Added 26.62%
213,488 $13.9 Million
Q4 2018

Feb 13, 2019

BUY
$60.54 - $79.0 $1.77 Million - $2.31 Million
29,178 Added 20.93%
168,603 $10.5 Million
Q3 2018

Nov 13, 2018

SELL
$71.28 - $78.92 $60.6 Million - $67.1 Million
-849,980 Reduced 85.91%
139,425 $10.8 Million
Q2 2018

Aug 30, 2019

BUY
$64.88 - $75.68 $617,852 - $720,700
9,523 Added 0.97%
989,405 $70.1 Million
Q2 2018

Aug 13, 2018

BUY
$64.88 - $75.68 $410,236 - $478,524
6,323 Added 0.65%
979,882 $69.4 Million
Q1 2018

Aug 28, 2019

SELL
$72.84 - $88.8 $285,241 - $347,740
-3,916 Reduced 0.4%
973,559 $73.4 Million
Q1 2018

May 14, 2018

BUY
$72.84 - $88.8 $12.1 Million - $14.7 Million
165,955 Added 20.45%
977,475 $73.7 Million
Q4 2017

Aug 28, 2019

SELL
$71.15 - $83.52 $575,176 - $675,175
-8,084 Reduced 0.99%
811,520 $58.1 Million
Q4 2017

Feb 13, 2018

BUY
$71.15 - $83.52 $58 Million - $68.1 Million
815,631 Added 20529.35%
819,604 $58.7 Million
Q3 2017

Nov 13, 2017

SELL
$72.11 - $85.47 $51.5 Million - $61.1 Million
-714,556 Reduced 99.45%
3,973 $321,000
Q2 2017

Aug 19, 2019

BUY
N/A
713,083 Added 13093.7%
718,529 $50.9 Million
Q1 2017

Aug 13, 2019

SELL
N/A
-2,290 Reduced 29.6%
5,446 $369,000
Q4 2016

Jul 30, 2019

BUY
N/A
918 Added 13.46%
7,736 $553,000
Q3 2016

Aug 07, 2019

SELL
N/A
-1,345 Reduced 16.48%
6,818 $539,000
Q2 2016

Jul 29, 2019

SELL
N/A
-129,350 Reduced 94.06%
8,163 $680,000
Q1 2016

Jul 25, 2019

SELL
N/A
-72,389 Reduced 34.49%
137,513 $12.6 Million
Q4 2015

Jul 24, 2019

BUY
N/A
40,408 Added 23.84%
209,902 $21.2 Million
Q3 2015

Jul 15, 2019

BUY
N/A
35,970 Added 26.94%
169,494 $16.6 Million
Q2 2015

Jul 08, 2019

BUY
N/A
58,547 Added 78.09%
133,524 $15.6 Million
Q4 2014

Aug 29, 2019

BUY
N/A
74,977
74,977 $7.07 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.